ZoneddyRuizDayaoMD

Oncology • Albuquerque, NM

Assistant Professor, Internal Medicine, University of New Mexico School of Medicine

Join to view full profile

Dr. Dayao is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dayao's full profile

Already have an account?

Office
1201 Camino de Salud NE
UNM Cancer Center
Albuquerque, NM 87102
Phone+1 505-272-4946

Fax+1 505-272-8060

Education & Training

University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2000 - 2003
Cook County Health and Hospitals SystemResidency, Internal Medicine, 1997 - 2000
University of the Philippines College of MedicineClass of 1995

Certifications & Licensure

NM State Medical License 2003 - 2026
MI State Medical License 2007 - 2011
IL State Medical License 2000 - 2005
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013

Clinical Trials

Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2007 Jul 01
Completed
Phase 3
A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients Start of enrollment: 2006 Jul 01
Completed
Phase 3
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab Start of enrollment: 2010 Mar 01
Completed
Phase 2
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Start of enrollment: 2011 May 16
Completed
Not Applicable
Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel Start of enrollment: 2016 May 24
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Developing questions to assess and measure patients' perceived survival benefit from adjuvant endocrine therapy in breast cancer: a mixed methods pilot study.
Bernard Tawfik, Kendal Jacobson, Ursa Brown-Glaberman, Mikaela Kosich, M Lee Van Horn
Clinical and Experimental Medicine. 2024-02-14
"Care needs to be integrated" Patient and provider perspectives on a cancer shared-care model.
Shoshana Adler Jaffe, Miria Kano, Stephanie Rieder, Amy C Gundelach, Tawny Boyce
Journal of Cancer Survivorship. 2023-10-27
2 citations
A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Allia...
Bernard Tawfik, Zoneddy R Dayao, Ursa Abigail Brown-Glaberman, V Shane Pankratz, Jacqueline M Lafky
Supportive Care in Cancer. 2023-10-17

Press Mentions

Change AgentJuly 21st, 2021
Cheryl Willman Named Head of Mayo Clinic Cancer Programs, Director of Cancer CenterMay 17th, 2021
Dr. Cheryl Willman Named Executive Director, Mayo Clinic Cancer Programs; Director, Mayo Clinic Comprehensive Cancer CenterMay 17th, 2021

Other Languages

Filipino